Fig. 6.
Overall survival according to age.
Overall survival time of patients treated with first-line 2-CdA+P (continuous line) or Chl+P (dotted line) analyzed for patients 55 years or younger (A) and older than 55 years (B).
Overall survival according to age.
Overall survival time of patients treated with first-line 2-CdA+P (continuous line) or Chl+P (dotted line) analyzed for patients 55 years or younger (A) and older than 55 years (B).
